
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.35 | -2.72% | 12.50 | 12.50 | 13.20 | 12.50 | 12.50 | 12.50 | 2,733 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 3.84B | 164.7M | 0.6049 | 24.10 | 3.5B |
COMPLETION OF BUYBACK
Glanbia PLC
2 June 2025
Glanbia plc completes EUR50m Share Buyback Programme
Glanbia plc, the Better Nutrition company ("Glanbia" or "the Company"), is pleased to announce the completion of the €50 million share buyback programme which was initially announced on 6 November 2024 and formally commenced on 16 December 2024.
Between 16 December 2024 and 30 May 2025, Glanbia deployed €50 million, repurchasing 4,073,073 ordinary shares on Euronext Dublin at an average price of €12.2757.
Following cancellation of repurchased shares, Glanbia will have 254,978,646 ordinary shares in issue.
J&E Davy completed the buyback programme on behalf of Glanbia independently of, and uninfluenced by, the Company.
For further information contact:
Liam Hennigan, Group Secretary and Head of Investor Relations: +353 86 046 8375
Martha Kavanagh, Director of Corporate Affairs: +353 87 646 2006
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions